Ablo Prudence Wachinou

Dr. Ablo Prudence Wachinou

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 April 2022 in The Lancet Respiratory Medicine
Verified
Journal Article
Closed access
AWAblo Prudence Wachinou
Ablo Prudence Wachinou
CHCorinne Houehanou
Corinne Houehanou
SASerge Ade
Serge Ade
TTTerence Totah
Terence Totah
MBMathieu Berger
Mathieu Berger
RHRaphael Heinzer
Raphael Heinzer

22 February 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MAMênonli Adjobimey
Mênonli Adjobimey
SASerge Ade
Serge Ade
AWAblo Prudence Wachinou
Ablo Prudence Wachinou
MEMarius Esse
Marius Esse
LYLydia Yaha
Lydia Yaha
CMCorinne Merle
Corinne Merle
Objectives: We sought to evaluate the yield, cost, feasibility, and acceptability of routine tuberculosis (TB) screening of pregnant women in Cotonou, Benin. Design: Mixed-methods, cross-sectional study with a cost assessment. Setting: Eight participating health facilities in Cotonou, Benin. Participants: Consecutive pregnant women presenting for antenatal care at any participating site who were not in labor or currently being treated for TB from April 2017 to April 2018. Interventions: Screening for the presence of TB symptoms by midwives and Xpert MTB/RIF for those with cough for at least two weeks. Semi-structured interviews with 14 midwives and 16 pregnant women about experiences with TB screening. Primary and secondary outcome measures: Proportion of pregnant women with cough of at least two weeks and/or microbiologically confirmed TB. The cost per pregnant woman screened and per TB case diagnosed in 2019 USD from the health system perspective. Results: Out of 4,070 pregnant women enrolled in the study, 94 (2.3%) had a cough for at least two weeks at the time of screening. The average (standard deviation) age of symptomatic women was 26 ± 5 years and 5 (5.3%) had HIV. Among the 94 symptomatic women, 2 (2.3%) had microbiologically confirmed TB for a TB prevalence of 49 per 100,000 (95% CI: 6 to 177 per 100,000) among pregnant women enrolled in the study. The average cost to screen one pregnant woman for TB was $1.12 USD and the cost per TB case diagnosed was $2271 USD. Thematic analysis suggested knowledge of TB complications in pregnancy was low, but that routine TB screening was acceptable to both midwives and pregnant women. Conclusion: Enhanced screening for TB among pregnant women is feasible, acceptable, and inexpensive per woman screened, however in this setting has suboptimal yield even if it can contribute to enhance TB case finding.

24 February 2022 in Pulmonary Medicine
Verified
Journal Article
Open access
PDF file
AWAblo Prudence Wachinou
Ablo Prudence Wachinou
NKNonvignon Marius Kêdoté
Nonvignon Marius Kêdoté
GPGeraud Padonou
Geraud Padonou
SASerge Adè
Serge Adè
JDJoaquin Darboux
Joaquin Darboux
GAGildas Agodokpessi
Gildas Agodokpessi
Introduction. Exposure to electrical and electronic equipment waste (e-waste) has become a growing health concern. The objective of this study was to measure the effect of exposure to e-waste on respiratory symptoms and on lung function parameters in workers involved in informal recycling activities in Cotonou city, Benin. Methods. This was a cross-sectional study, in which exposed e-waste workers in Cotonou city were randomly selected. A matching nonexposed group based on age and sex was recruited from the general population. Respiratory symptoms were investigated using a questionnaire adapted from the British Medical Research Council’s standardized respiratory questionnaire. Participants underwent lung function test using a portable spirometer (MIR SPIROBANK). Data were analyzed with STATA version 15 software. Results. The overall prevalence of respiratory symptoms in e-waste workers was statistically higher in the exposed group (33.1% vs. 21.6%; ). Chest tightness (11.8% vs. 2.1%; ) and breathlessness (6.8% vs. 1.4%; ) were the most reported symptoms by e-waste workers. Lung function testing showed a higher proportion of disorders among e-waste workers (25.0% vs. 14.9%, ), with a higher proportion of probable restrictive (10.8% vs. 2.7, ) and mixed (4.1% vs. 0%, ) ventilatory disorders. Handling or working with e-waste was found associated with a significant reduction in forced expiratory volume in one second (FEV1) by 0.4 L (95% CI: 0.3-0.6) and forced vital capacity (FVC) by 0.75 L (95% CI: 0.6-0.9) after adjustment for age, BMI, smoking habits, asthma history, and daily income. Conclusion. Work involving e-waste is associated with a higher prevalence of respiratory symptoms and with an increased risk of FEV1 and FVC decline, as well as of lung function impairment, particularly of restrictive disorders. Further studies to better clarify this association are needed. Awareness on this major public health threat should be raised in other sub-Saharan and Asian urban areas.

18 January 2024 in BMJ Open
Verified
Journal Article
Open access
PDF file
EAElizabeth Tabitha Abbew
Elizabeth Tabitha Abbew
NLNatalie Lorent
Natalie Lorent
AMAnita Mesic
Anita Mesic
AWAblo Prudence Wachinou
Ablo Prudence Wachinou
DODorcas Obiri-Yeboah
Dorcas Obiri-Yeboah
LLLutgarde Lynen
Lutgarde Lynen
Introduction In sub-Saharan African (SSA) countries endemic for tuberculosis (TB), previous TB is a significant risk factor for non-tuberculous mycobacterial pulmonary disease (NTM-PD). The deployment of GeneXpert MTB/RIF in pulmonary TB diagnostic work-up regularly identifies symptomatic patients with a positive smear microscopy but negative GeneXpert, indicative of NTM presence. This scoping review outlines recent evidence for NTM-PD diagnosis and management in SSA. Objective The review’s objective was to outline the risk factors, available diagnostics, management options and outcomes of NTM-PD in high-burden TB settings in SSA using the population-concept-context framework. Design and data sources We searched existing literature from PubMed, Web of Science, African Journals Online, Google Scholar and grey literature. Studies published between January 2005 and December 2022 were retained. Data were extracted into Rayyan software and Mendeley and summarised using Excel. Results We identified 785 potential articles, of which 105 were included in the full-text review, with 7 papers retained. Included articles used international criteria for diagnosing NTM-PD. Multiple papers were excluded due to non-application of the criteria, suggesting challenging application in the SSA setting. Identified risk factors include previous TB, smoking and mining. Most commonly, chest radiography and not CT was used for the radiological diagnosis of PD, which may miss early changes related to NTM-PD. Molecular methods for NTM species identification were employed in research settings, usually at referral centres, but were unavailable for routine care. Most studies did not report a standardised approach to treatment and they were not offered treatment for the specific disease, marking a lack of guidance in treatment decision-making. When treatment was provided, the outcome was often not reported due to the lack of implementation of standardised outcome definitions. Conclusions These outlined challenges present a unique opportunity for researchers to undertake further studies in NTM-PD and proffer solutions more applicable to SSA.

1 November 2015 in Revue des Maladies Respiratoires
Verified
Journal Article
Closed access
GAG. Agodokpessi
G. Agodokpessi
GAG. Ade
G. Ade
NDN. Dovoedo
N. Dovoedo
SAS. Ade
S. Ade
AWAblo Prudence Wachinou
Ablo Prudence Wachinou
MGM. Gninafon
M. Gninafon

1 December 2015 in BMC Health Services Research
Verified
Journal Article
Open access
PDF file
SASerge Ade
Serge Ade
ATArnaud Trebucq
Arnaud Trebucq
Anthony HarriesAnthony Harries
Anthony Harries
GAGabriel Ade
Gabriel Ade
GAGildas AGODOKPESSI
Gildas AGODOKPESSI
SASévérin Anagonou
Sévérin Anagonou
In the “Centre National Hospitalier de Pneumo-Phtisiologie” of Cotonou, Benin, little is known about the characteristics of patients who have not attended their scheduled appointment, the results of tracing and the possible benefits on improving treatment outcomes. This study aimed to determine the contribution of tracing activities for those who missed scheduled appointments towards a successful treatment outcome. A retrospective cohort study was carried out among all smear-positive pulmonary tuberculosis patients treated between January and September 2013. Data on demographic and diagnostic characteristics and treatment outcomes were accessed from tuberculosis registers and treatment cards. Information on those who missed their scheduled appointments was collected from the tracing tuberculosis register. A univariate analysis was performed to explore factors associated with missing a scheduled appointment. Of 457 patients (410 new smear-positive and 47 retreatment tuberculosis), 37 (8 %) missed one or more of their appointments with a total of 44 episodes of missed appointments. The 3.5th (32 %) and 5th (43 %) month appointments were the ones most likely to be missed. Being male was associated with a higher risk of missing appointments (RR = 4.2; 95 % CI = 1.5–11.8, p = 0.004) while having HIV infection was associated with a lower risk (RR = 0.3, 95 % CI = 0.1–0.9, p = 0.03). Principal reasons for missed appointments were travelling outside Cotonou (34 %) and feeling better (21 %). In 24 (55 %) of these 44 episodes of missed appointments, contact was made with the patient who returned to the programme. These follow-up activities increased the treatment success by 4 %. In Cotonou, Benin, less than 10 % of tuberculosis patients miss at least one of their scheduled appointments. Tracing activities increase the treatment success rate by 4 % and current on-going practices in the Programme need to be endorsed and encouraged.